register

Human Resources

Men are more likely to be manipulative colleagues than women

Health Industry Hub | August 17, 2020 |

Human Resources: An Australian study of almost 800 people has found that men are more likely to engage in malicious emotional manipulation in the workplace than women.

This study investigated people’s willingness to emotionally manipulate others maliciously and disingenuously in the workplace. It also examined the role of gender, emotional intelligence, and the Dark Triad traits (machiavellianism (a manipulative attitude), narcissism (excessive self-love), and psychopathy (lack of empathy) in this destructive behaviour.

T‐tests revealed that females were significantly less likely than males to engage in both malicious and disingenuous emotional manipulation.

The study found that emotional manipulation is higher in men who have a relentless drive to achieve goals, and in women with broader deceptive tendencies. The study also suggests there is a ‘dark side to emotional intelligence’ at work, as those who were more in touch with their own emotions and those of others, also tended to be more manipulative.

In females, the magnitude of correlations (small to moderate) between the Dark Triad traits and both forms of emotional manipulation were similar. In males, both forms of emotional manipulation most strongly correlated with Machiavellianism, followed by narcissism, then psychopathy. 

This study is the first to demonstrate that good emotional intelligence skills can facilitate undesirable workplace behaviours.


News & Trends - Pharmaceuticals

March PBAC agenda unveiled amid tensions over 'unprecedented' volume of submissions

March PBAC agenda unveiled amid tensions over ‘unprecedented’ volume of submissions

Health Industry Hub | November 29, 2024 |

The Department of Health has released the agenda for the March 2025 Pharmaceutical Benefits Advisory Committee (PBAC) meeting, unveiling plans […]

More


News & Trends - MedTech & Diagnostics

Johnson & Johnson MedTech exits DePuy Synthes spine portfolio

J&J MedTech exits DePuy Synthes spine portfolio

Health Industry Hub | November 29, 2024 |

Johnson & Johnson MedTech will officially exit the DePuy Synthes Spine portfolio in Australia tomorrow, November 30, as part of […]

More


News & Trends - Pharmaceuticals

Home-grown hypertension polypill heads for regulatory approval

Home-grown hypertension polypill heads to regulatory approval

Health Industry Hub | November 29, 2024 |

Australian-supported research has revealed remarkable Phase III clinical trial results for an innovative triple drug combination in the treatment of […]

More


News & Trends - Pharmaceuticals

Will Australia become first country to eliminate HIV transmission by 2030?

Will Australia become first country to eliminate HIV transmission by 2030?

Health Industry Hub | November 29, 2024 |

In the lead-up to World AIDS Day on December 1, the Albanese Government has unveiled the 9th National HIV Strategy, […]

More


This content is copyright protected. Please subscribe to gain access.